<DOC>
	<DOCNO>NCT01704794</DOCNO>
	<brief_summary>The purpose study determine antioxidant effect prolong use sorghum bicolor ( jobelyn ) increase level plasma superoxide dismutase glutathione reductase patient sickle cell disease determine improvement quality life patient .</brief_summary>
	<brief_title>Quality Life Study Sickle Cell Patients Treated With Jobelyn ( Sorghum Bicolor Extract )</brief_title>
	<detailed_description>Jobelyn extract sorghum bicolor popular Nigeria herbal food supplement . This extract show high oxygen radical absorbance capacity ( ORAC 37,622micro mole TE/g ) compare botanical preparation 1 . A second proven property anti inflammatory effect selective COX 2 inhibition 2 . It also show correct anaemia induce experimental rabbit trypanosome brucei brucei 3 . Jobelyn consume herbal nutritional supplement many disorder include sickle cell disease Nigeria without complaint 15 year . The toxicology profile impressive wide therapeutic range . Nigeria one country large burden sickle cell disease . It chronic genetic disorder account absenteeism school work place . There also significant shorten life span affect patient . Sickle cell anaemia present recurrent bone pain progressive organ damage affect negatively quality life patient . Available measure use include use hydroxyurea , chronic acute red cell transfusion haematopoietic stem cell transplantation . These limitation term adverse effect , cost availability . The pathogenesis involve intracellular precipitation mutant haemoglobin , rigidity cell , adhesion cell endothelium . These cause recurrent tissue hypoxia reperfusion cause release reactive oxygen series agent inflammation . The extract sorghum therefore expect improve quality life patient . Previous work do , investigate long time effect extract quality life sickle cell patient . This study therefore design compare quality life patient 500mg daily , 250mg daily 2mg daily jobelyn use adjusted standard tool . The secondary outcome study change indicator inflammation systemic antioxidant patient . The study period 12 month period shall involve weather condition region .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Proguanil</mesh_term>
	<criteria>1 . AGE : 14 To 40 year 2 . SEX : Both sex 3 . Homozygous S gene ( SS ) 1 . Age 14 year 40 year 2 . Evidence organ failure i.e heart failure , renal failure 3 . No consent study 4 . Poor adherence treatment irregular visit clinic 5 . Presence chronic inflammation 6 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Sickle Cell Anemia</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Antioxidant</keyword>
	<keyword>Anti inflammatory</keyword>
	<keyword>Sorghum bicolor</keyword>
</DOC>